Ozempic: The Swiss Army Knife of Weight Loss Drugs
Photo by Simon Schwyter on Unsplash
One in ten Americans is now casually poking themselves with GLP-1 drugs like Ozempic, Wegovy, or Mounjaro — not just to ditch carbs, but to fight heart disease, dementia, and even addiction. Experts warn, 'We are entering the Ozempic era,' but also caution about unknown 20- or 30-year effects. While some claim these meds zap junk food cravings—hello, baked beans obsession!—others wonder if suppressing desire might turn us into 'emotionless robots.' GLP-1s are the pharmaceutical equivalent of a Gila monster's secret weapon, solving everything but how to explain to your hipster barista why you're craving tomatoes over triple lattes.
Share the Story
(1 of 3)Source: Vox | Published: 7/28/2025 | Author: Dylan Scott
More Articles in Health
Digital Nomad Trapped in Lisbon FOMO, Ends Up BFF Ghosted
Businessinsider.com
Motorola Razr Flip Phones Finally Told They’re Secure Enough for 2027
Theverge
KPMG’s Consulting Business Dies Dramatically While Staff Take a Hike
Businessinsider
90-Year-Old Dad Outsources Bathing to Jovial Nigerian and Ghanaian Carers
Businessinsider
Woman Ages Backwards in Online Writing Class, Still Loses to 21-Year-Old
Businessinsider
Billionaire’s Daughter’s Brain Hemorrhage Detected Belatedly By $299 Ring
Businessinsider
Dietitians Unite to Demand We Eat More Beans, Save Humanity from Boredom
Businessinsider
Mark Cuban Declares AI Too Empathetic to Replace Doctors, Only Bullshit Jobs Fear
Businessinsider
Ina Garten Declares Scrambled Eggs The Pinnacle of Pasta-Inspired Brilliance
Businessinsider